Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-037497
Filing Date
2023-06-15
Accepted
2023-06-15 17:51:27
Documents
1
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6160
  Complete submission text file 0001209191-23-037497.txt   7631
Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310 SEATTLE WA 98102
Business Address
Paya Carlos V (Reporting) CIK: 0001606244 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 231018720

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)